NATIONAL BANK OF CANADA /FI/
BankPosition in EPRX — Eupraxia Pharmaceuticals Inc.
CIK 926171
MONTREAL, A8
Position in EPRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,599
-$1,825 QoQ
Shares Held
359
-38.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 54 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NATIONAL BANK OF CANADA /FI/ holds $751,526,651 across 111 Biotechnology names. EPRX ranks #71 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
6,298,000 | $174,454,600 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
1,749,000 | $170,090,250 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
272,117 | $121,511,122 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,006 | $100,447,834 | |
| 5 | MRNA |
Moderna, Inc.
|
1,817,001 | $92,303,650 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
63,607 | $21,045,647 | |
| 7 | ASND |
Ascendis Pharma A/S
|
80,017 | $18,302,288 | |
| 8 | INSM |
INSMED Inc
|
104,758 | $17,130,027 |
All Filings in EPRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,599 | 359 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,424 | 586 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,203 | 882 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,204 | 730 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $2,505 | 764 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $136 | 43 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $394 | 150 | Shares | Defined | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||